
aTyr Pharma Inc
NASDAQ:ATYR

Intrinsic Value
The intrinsic value of one
ATYR
stock under the Base Case scenario is
4.23
USD.
Compared to the current market price of 3.97 USD,
aTyr Pharma Inc
is
Undervalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
aTyr Pharma Inc
Fundamental Analysis


Revenue & Expenses Breakdown
aTyr Pharma Inc
Balance Sheet Decomposition
aTyr Pharma Inc
Current Assets | 76.3m |
Cash & Short-Term Investments | 66m |
Receivables | 1.8m |
Other Current Assets | 8.5m |
Non-Current Assets | 15.3m |
PP&E | 12.2m |
Other Non-Current Assets | 3.1m |
Free Cash Flow Analysis
aTyr Pharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
aTyr Pharma Inc
Revenue
|
235k
USD
|
Operating Expenses
|
-68.3m
USD
|
Operating Income
|
-68.1m
USD
|
Other Expenses
|
4.2m
USD
|
Net Income
|
-63.8m
USD
|
ATYR Profitability Score
Profitability Due Diligence
aTyr Pharma Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Score
aTyr Pharma Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
ATYR Solvency Score
Solvency Due Diligence
aTyr Pharma Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
aTyr Pharma Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATYR Price Targets Summary
aTyr Pharma Inc
According to Wall Street analysts, the average 1-year price target for
ATYR
is 18.76 USD
with a low forecast of 9.09 USD and a high forecast of 36.75 USD.
Dividends
Current shareholder yield for ATYR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ATYR
stock under the Base Case scenario is
4.23
USD.
Compared to the current market price of 3.97 USD,
aTyr Pharma Inc
is
Undervalued by 6%.